FDA Approved: ERLEADA — Supplemental Application (Janssen Products, LP)

View source ↗

Summary

FDA approved a supplemental application for ERLEADA (apalutamide) by Janssen Products, LP, prompting changes to the product labeling. The action expands or upda…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Castration-resistant Prostate Cancer
• Non-metastatic Castration-resistant Prostate Cancer

Drugs mentioned

• ERLEADA (apalutamide)

Snippet

SUPPL AP for ERLEADA (APALUTAMIDE)